AQR Capital Management
EOLS icon

AQR Capital Management’s Evolus EOLS Stock Holding History

AQR Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Buy
25,677
+2,700
+12% +$13.1K ﹤0.01% 3681
2025
Q4 		$153K Sell
22,977
-35,366
-61% -$240K ﹤0.01% 3416
2025
Q3 		$358K Sell
58,343
-12,922
-18% -$101K ﹤0.01% 2992
2025
Q2 		$656K Buy
71,265
+4,527
+7% +$46.3K ﹤0.01% 2459
2025
Q1 		$803K Sell
66,738
-90,306
-58% -$1.18M ﹤0.01% 2163
2024
Q4 		$1.73M Buy
157,044
+7,482
+5% +$105K ﹤0.01% 1606
2024
Q3 		$2.42M Buy
149,562
+77,555
+108% +$1.08M ﹤0.01% 1406
2024
Q2 		$781K Buy
72,007
+17,971
+33% +$221K ﹤0.01% 1867
2024
Q1 		$757K Buy
54,036
+3,883
+8% +$50.5K ﹤0.01% 1801
2023
Q4 		$528K Sell
50,153
-2,588
-5% -$23.1K ﹤0.01% 1858
2023
Q3 		$482K Sell
52,741
-198
-0.4% -$1.78K ﹤0.01% 1857
2023
Q2 		$385K Buy
52,939
+15,951
+43% +$138K ﹤0.01% 1859
2023
Q1 		$313K Sell
36,988
-65,936
-64% -$596K ﹤0.01% 1934
2022
Q4 		$773K Sell
102,924
-5,857
-5% -$45.4K ﹤0.01% 1647
2022
Q3 		$876K Buy
108,781
+98,779
+988% +$1.05M ﹤0.01% 1570
2022
Q2 		$116K Sell
10,002
-2,143
-18% -$25.3K ﹤0.01% 2073
2022
Q1 		$136K Sell
12,145
-115,608
-90% -$985K ﹤0.01% 2113
2021
Q4 		$832K Buy
127,753
+12,055
+10% +$82.7K ﹤0.01% 1639
2021
Q3 		$882K Buy
115,698
+31,612
+38% +$327K ﹤0.01% 1615
2021
Q2 		$1.06M Buy
+84,086
New +$925K ﹤0.01% 1558

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's EOLS Position: Q1 2026 in Review

AQR Capital Management increased its Evolus (EOLS) stake by 12% in Q1 2026, buying an estimated $13.1K and bringing the position to 25,677 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3681.

AQR Capital Management first reported a position in EOLS in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.42M in Q3 2024. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • AQR Capital Management held 25,677 shares of Evolus worth $106K as of Q1 2026.
  • AQR Capital Management bought 2,700 Evolus shares in Q1 2026, an estimated $13.1K.
  • Evolus made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3681 holding.
  • AQR Capital Management first reported a position in Evolus in Q2 2021 and has held it in 20 quarters since.
  • AQR Capital Management's Evolus position peaked at $2.42M in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.